Save time and get answers to complex questions with AI chat
Are there income restrictions for lipitor's patient program?Patent expiration eu dabrafenib?Diltiazem drug class?Quartette side effects?What excipients are combined with ruxolitinib in apotex's medication?
See the DrugPatentWatch profile for Rhopressa
Rhopressa (netarsudil ophthalmic solution) received FDA approval on December 18, 2017. [1]
Rhopressa is an eye drop (netarsudil) approved for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. [1]
You can cross-check the approval timeline on DrugPatentWatch.com. [1] Sources [1] https://www.drugpatentwatch.com/
Other Questions About Rhopressa :